Women's Health Policy

ABORTION IN THE U.S.

Variability in Rebimbursement Rates for State-funded Abortion Services for Medicaid Enrollees: A 2026 Update

This analysis reveals that while more states have begun using their own funds to cover abortion services for Medicaid enrollees since the U.S. Supreme Court’s Dobbs decision, only a handful have significantly increased reimbursement rates for providers, potentially undermining access to care for low-income patients. After examining physician fee schedules for abortions provided to Medicaid enrollees since 2024, KFF finds that reimbursement rates vary dramatically across states, and that most states don't substantially increase payment rates for later-pregnancy procedures, despite their higher costs and complexity.

CONTRACEPTIve care IN THE U.S.

An Update on Medicaid, Title X and Planned Parenthood

This brief provides an update on Planned Parenthood clinic closures and participation in the Title X program amid substantial policy changes resulting in funding reductions. These changes include the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.

SELECTED RESOURCES

Over-the-Counter Oral Contraceptive Pills

In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.

featured

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Women’s Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials
  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.
  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.
  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.
  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Stay informed.

Stay informed.

Filter

241 - 250 of 876 Results

  • Most Women are in Favor of Making Birth Control Pills Available Over the Counter without a Prescription if Research Shows they are Safe and Effective

    News Release

    A new KFF survey finds that more than three-quarters (77%) of females ages 18-49 favor making birth control pills available without a doctor’s prescription if research shows they are safe and effective. Among those who favor making birth control pills available over the counter and who currently use prescription oral contraception, 60% say they would be likely to use over-the-counter birth control pills. Most say the main reason is convenience (59%). Many females who would…

  • What Women Think of the Core Issue in the Hobby Lobby Case

    From Drew Altman

    This was published as a Wall Street Journal Think Tank column on June 30, 2014. The Supreme Court decision upholding Hobby Lobby’s ability to refuse to cover certain contraceptive services based on its owners’ religious beliefs has set off a wave of analysis of what the decision means. That will not be resolved anytime soon. But we do know what women think of the policy issue at the core of the case. Overall, by a margin of…

  • Putting Men’s Health Care Disparities On The Map: Examining Racial and Ethnic Disparities at the State Level

    Report

    This report documents the persistence of disparities between white men and men of color -- and among different groups within men of color -- on 22 indicators of health and well-being, including rates of diseases such as AIDS, cancer, heart disease and diabetes, as well as insurance coverage and health screenings. It also catalogues disparities in factors that influence health and access to care such as income and education, and other social determinants of health.

  • Legal Challenges to the FDA Approval of Medication Abortion Pills

    Issue Brief

    This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA's approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.

  • The Comstock Act: Implications for Abortion Care Nationwide 

    Issue Brief

    This brief provides background on the Comstock Act, reviews how it has been interpreted by the Biden Administration’s DOJ, and considers how it could be enforced by an administration that is hostile toward abortion to severely restrict the distribution of drugs and supplies used for abortion, with implications for abortion access in all states across the country.

  • Legal Challenges to State Abortion Bans Since the Dobbs Decision

    Issue Brief

    This issue brief presents an overview of the legal challenges presented in state courts since the Dobbs ruling in June 2022 and highlights some of the novel strategies that are being used to defend access to abortion in states that have enacted abortion bans.

  • The Latest on Medication Abortion Access: The Court Awaits the FDA Review

    Quick Insights

    Despite for calls from Republican leaders and anti-abortion organizations for the FDA to act quickly, the Louisiana district court has given the FDA until October 7, 2026, one month before the midterms, to file a report with the status of its review and any updated timeframe for completion. In the meantime, clinicians may continue to mail mifepristone to pregnant patients seeking abortions regardless of where they live.